Evoke Pharma Inc investor relations material
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. Evoke develops Gimoti (metoclopramide) Nasal Spray, which is indicated for the treatment of symptoms associated with acute and recurrent diabetic gastroparesis in females ages 18 years or older. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.